Background: Subclinical zinc deficiency (SZD) represents the common zinc malnutrition phenotype. However, its
Introduction
Apart from studies that have used cell cultures (1, 2), oxidative damage has been reported in response to insufficient dietary zinc supply in vivo (3, 4) . Most studies thus far have investigated the relation between zinc homeostasis and redox metabolism during clinical zinc deficiency. However, this condition is associated with secondary metabolic imbalance, which impairs the resolution of measurements. This complicates identifying the effects that result directly from zinc homeostatic regulation. Therefore, the basis for the association of zinc deficiency with oxidative stress is currently not well understood. The most common phenotype of zinc malnutrition in humans and animals is presumably a subclinical zinc deficiency (SZD) 4 (5) . SZD is characterized by a total absence of clinical symptoms (e.g., growth retardation, anorexia, tissue necrosis) (6) and, at the same time, a decreased zinc status. We have recently published an experimental model of short-term SZD in weaned piglets (7) , thus giving us an opportunity to investigate the potential relation between the zinc supply status and redox metabolism with high resolution.
Because of its high metabolic turnover, cardiac tissue has the highest production of reactive oxygen species (ROS) per gram of tissue. At the same time, it has a lower antioxidative capacity than other organs. Hence, it is quite susceptible to imbalances in redox metabolism (8) . This is especially true for growing individuals, who have considerably higher heart rates than adults (9) . Therefore, early events in the development of zinc deficiency-dependent oxidative stress may be captured in the heart muscles of growing individuals.
We aimed to provide the first data to our knowledge on the adaption of cardiac redox metabolism to short-term SZD in weaned piglets. We hypothesized that this condition is associated with a decrease in cardiac antioxidative capacity and changes in stress-associated cardiac gene expression that may be accompanied by a decrease in the zinc status of the heart muscle.
Methods
This study was registered and approved by the responsible animal welfare authorities (Federal State of Bavaria: case number 55.2.1.54-2532.3.63-11).
Animals and diets. Forty-eight weaned German Large White 3 German Landrace 3 Piétrain piglets from 6 litters (50% castrated males and 50% females) aged 4 wk and with an initial mean 6 SD body weight of 8.5 6 0.27 kg were purchased from Christian Hilgers. The piglets were fed a basal diet ad libitum that consisted mainly of corn and soybean meal with adequate dietary zinc supplementation as analytical-grade ZnSO 4 Á 7H 2 O (analyzed final concentration of dietary zinc: 88.0 mg/kg) (Merck KGaA) within a 2-wk acclimatization phase. The basal diet contained all nutrients according to published piglet requirements (Supplemental Table 1 ) (10).
The piglets were assigned to 8 feeding groups in a completely randomized block design considering a balanced distribution of life weight, litter, and sex (n = 6/group). During a total experimental period of 8 d, all piglets were fed restrictively (450 g/d) the same diet as during the acclimatization phase but with a varying supplementation of ZnSO 4 Á 7H 2 O (analyzed final concentrations of dietary zinc: 28.1, 33.6, 38.8, 42.7, 47.5, 58.2, 67.8, and 88.0 mg/kg) (Supplemental Table 2 ). The group that was supplied 88.0 mg/kg served as the control because it represented the initial feeding situation during acclimatization. As reported by Brugger et al. (7), 1-factor ANOVA combined with the Student-Newman-Keuls Test (with diet as the independent variable) identified no significant differences between experimental and control diets except for the analyzed dietary zinc concentration, which differed by P < 0.0001. These analyses were performed on the basis of 3 separate samples/ batch (diet) that were screened independently (duplicate weighing) for crude nutrient and trace metal (iron, zinc, copper, manganese) concentrations.
Sampling conditions. Diet samples were stored in air-tight polyethylene bottles at 220°C and milled through a 0.5-mm screen before chemical analysis. All animals were killed by exsanguination under anesthesia (azaperone and ketamine) without fasting after 8 experimental days, and the heart muscle was removed. Samples for chemical analyses were snap-frozen in liquid nitrogen and stored at 280°C. Samples for the gene expression analysis were incubated in RNAlater (Thermo Scientific) according to the manufacturerÕs instructions and stored at 280°C.
Analyses of dry matter and total zinc in diets and cardiac tissue. Brugger et al. (7) have published details on the dry matter and zinc analyses in diets and soft tissue. Zinc concentrations were measured by atomic absorption spectrometry (NovAA 350; Analytik Jena AG) after microwave wet digestion (Ethos 1; MLS GmbH). Table 1 for detailed information on the statistical measures of the respective regression models). Values are arithmetic means 6 SDs, n = 6. Diet zinc, dietary zinc; DM, dry matter; GSH, reduced glutathione; HDA, H 2 O 2 -detoxification activity (U = mmol H 2 O 2 ) of per-minute activity change per milligram of total protein within the reaction mixture.
Analyses of cardiac concentrations of glutathione and tocopherols. Glutathione and tocopherols were assayed with the use of HPLC on a VWR International Hitachi LaChrom Elite system. Tissues were homogenized before extraction (25 and 50 mg fresh weight/sample for the extraction of glutathione and tocopherols, respectively) with the FastPrep system (MP Biomedicals).
Cardiac concentrations of reduced glutathione (GSH) and oxidized glutathione (GSSG) were analyzed according to Asensi et al. (11) with the use of a Spherisorb NH2 column (i.d., 4.6 mm; o.d., 250 mm; particle size, 5 mm) (Waters). External (L-glutathione-reduced and L-glutathioneoxidized) (Sigma-Aldrich) and internal (g-L-glutamyl-L-glutamic acid (Acros Organics) standards were used for quantification.
Cardiac concentrations of a-tocopherol and g-tocopherol were assayed according to Balz et al. (12) with the use of a LiChrosorb silica 60 column (i.d., 4 mm; o.d., 250 mm; particle size, 5 mm) and a 4 3 4 silica 60 precolumn (Merck KGaA). External standards (a-and g-tocopherol) (Sigma-Aldrich) were used for quantification.
Cardiac H 2 O 2 -detoxification activity. Protein concentration in homogenized tissues was determined as described previously (13) . The total protein concentration was used to normalize the H 2 O 2 -detoxification activity (HDA). Cardiac HDA was quantified with the use of the catalase activity assay from Beers and Sizer (14) . Quartz cuvettes were applied with a total reaction volume of 3 mL that consisted of 100 mL diluted tissue homogenate, 1.9 mL ultrapure water (type 1), and 1 mL 30% Gene expression analysis. Primer design, assay quality control, and chemical procedures (total RNA extraction, qRT-PCR) were carried out according to Brugger et al. (7) . The quantity and purity of the extracts was measured on a NanoDrop 2000 (Thermo Scientific) (total RNA quantity: 900 6 91.1 ng/mL; OD 260 nm :OD 280 nm ratio: 2.13 6 0.09; OD 260 nm :OD 230 nm ratio: 2.17 6 0.07). Total RNA integrity was assayed with the use of automated capillary gel electrophoresis (Experion; Biorad) (RNA quality index: 6.60 6 0.32). Primer pairs (Eurofins Scientific) were designed for the potential reference transcripts glyceraldehyde 3-phosphate dehydrogenase (GAPDH), b-glucuronidase (GUSB), ribosomal protein subunit 18 (RPS18), and b-actin (ACTB) as well as the target transcripts metallothionein 1A (MT1A), metallothionein 2B (MT2B), superoxide dismutase (SOD) 1, SOD2, glutathione peroxidase 1 (GPX1), peroxiredoxin (PRDX) 1, PRDX3, PRDX4, glutathione reductase (GSR), catalase (CAT), tumor protein p53 (TP53), Fas cell-surface death receptor (FAS), B-cell lymphoma 2-associated X protein (BAX), etoposide-induced 2.4 (EI24), shisa family member 5 (SHISA5), insulin-like growth factor-binding protein 3 (IGFBP3), caspase (CASP) 3, CASP8, CASP9, cyclin-dependent kinase inhibitor 1A (CDKN1A), growth arrest and DNA damage-inducible a (GADD45A), and stratifin (Supplemental Tables 3 and 4 ) with the use of published porcine sequence information (15) . All oligonucleotides bind to homologous regions of respective transcripts to amplify potential variants. We identified GAPDH, TP53, and SHISA5 as suitable reference genes for data normalization (16) . The 2 2DDCt method (17) was used to normalize the gene expression data because the determination of the amplification efficiency (7) revealed comparable values between 95% and 100% of applied qRT-PCR assays.
Statistical analyses. Data were analyzed with the use of SAS 9.4 (SAS Institute Inc.). Linear and broken-line regression models were calculated on the basis of independent group means relative to dietary zinc concentration (n = 8). The significant regression models with the highest coefficients of determination (R 2 ) were used for presenting and interpreting data. Furthermore, Pearson correlation coefficients (r) were estimated for all measured parameters and gene expression patterns relative to changes in cardiac zinc concentration. All 2 2DDCt gene expression data were log-transformed (decadal logarithm) before statistical analysis and data presentation. P # 0.05 was considered to be significant.
Results
No piglets showed signs of clinical zinc deficiency (e.g., growth depression, anorexia, impaired organ development, tissue necrosis, etc.) (6) throughout the entire trial.
Response of parameters of cardiac antioxidative capacity to changes in dietary zinc concentration. Linear and brokenline models were used to analyze the response of cardiac antioxidative capacity to declining dietary zinc concentration. Statistical measures of the respective regression curves are shown in Figure 1 and Table 1 .
Cardiac GSH concentration did not change with a reduction in dietary zinc concentration from 88.0 mg Zn/kg to a significant breakpoint of 57.6 mg Zn/kg (P < 0.0001). Below this threshold, it linearly decreased with further declining dietary zinc (P = 0.004). Cardiac GSSG and the GSH:GSSG ratio did not change with a Cardiac response to subclinical zinc deficiency 523 reduction in dietary zinc concentration (P = 0.42 and 0.25, respectively; data not shown). Cardiac a-tocopherol concentration remained stable between 36.0 and 88.0 mg Zn/kg. A further reduction of the dietary zinc concentration below the significant threshold of 36.0 mg/kg (P < 0.0001) promoted a linear decrease of a-tocopherol concentration (P = 0.03). Cardiac g-tocopherol concentrations fell below the lower limit of detection in all analyzed samples (0.2 nmol/mg tissue dry matter). Cardiac HDA linearly declined with the reduction in dietary zinc concentration over the whole range of applied zinc doses (P = 0.007).
Response of cardiac proapoptotic and antioxidative gene expression to changes in dietary zinc concentration. Figure  2 presents the broken-line regression curves that highlight the response of cardiac proapoptotic and antioxidative gene expression to changes in dietary zinc concentration. The statistical measures of the respective regression curves are shown in Table 2 .
Relative BAX gene expression remained stable with declining dietary zinc concentration until a significant threshold of 55.3 mg Zn/kg (P = 0.001), below which it linearly increased inversely to a further reduction in dietary zinc. However, this slope was not significant (P = 0.1). It is noteworthy that the linear regression analysis yielded a significant linear increase inversely to changes in dietary zinc concentration from 88.0 to 28.1 mg/kg [0.002 Log 10 (2 2DDCt )/mg dietary Zn; P # 0.05; data not shown].
Cardiac CASP9 gene expression remained unaffected between 33.8 and 88.0 mg Zn/kg. Below the significant breakpoint of 33.8 mg Zn/kg (P < 0.0001), CASP9 expression linearly increased inversely to a further reduction in dietary zinc concentration (P = 0.009).
Cardiac CAT gene expression remained stable in response to declining dietary zinc concentration until a significant breakpoint of 36.5 mg Zn/kg (P < 0.0001), below which a linear upregulation occurred inversely to further declining dietary zinc (P = 0.04).
Cardiac GSR gene expression exhibited a response pattern similar to that of cardiac CAT. The significant breakpoint of the regression curve was 41.3 mg Zn/kg (P < 0.0001). Below this threshold, expression linearly increased inversely to the declining dietary zinc concentration (P = 0.007).
The remaining cardiac genes involved in antioxidative defense and apoptosis (CASP3, CASP8, FAS, GADD45A, GPX1, IGFBP3, CDKN1A, EI24, PRDX1, PRDX3, PRDX4, SOD1, SOD2) were not significantly affected by the dietary zinc concentration (P > 0.8 in all cases; data not shown).
Response of measures of cardiac zinc status to changes in dietary zinc concentration. Figure 3 shows the broken-line and linear regression models that describe the response of measures of cardiac zinc status to changes in dietary zinc concentration. The statistical measures of the respective regression curves are shown in Table 3 .
Declining dietary zinc concentration was directly associated with cardiac zinc concentration (P = 0.006) in piglets fed zinc doses above a significant breakpoint of 42.7 mg Zn/kg (P < 0.0001). Below this threshold, cardiac zinc concentration was inversely associated with the dietary zinc concentration (P = 0.04). Cardiac Table 2 for detailed information on the statistical analysis of the respective regression models). Values are arithmetic means 6 SDs, n = 6. BAX, B-cell lymphoma 2-associated X protein; CASP9, caspase 9; CAT, catalase; Diet zinc, dietary zinc; GSR, glutathione reductase; Log 10 (2 2DDCt ), decadal logarithm of the relative gene expression value according to Livak and Schmittgen (17) .
MT1A gene expression linearly decreased with the dietary zinc concentration between 28.1 and 88.0 mg Zn/kg diet (P = 0.02). Cardiac MT2B gene expression was not affected by dietary zinc (P = 0.29; data not shown). It is noteworthy that plasma zinc concentrations were directly associated with the dietary zinc concentration between 28.1 and 88.0 mg Zn/kg (P < 0.0001) [data presented and discussed by Brugger et al. (7)].
Response of heart antioxidative capacity and target gene expression to changes in the tissue zinc concentration. Cardiac FAS, EI24, and CDKN1A gene expression exhibited a significant positive correlation to cardiac zinc concentration in groups fed #42.7 mg Zn/kg (r = 0.97, 0.99, and 0.99 and P = 0.03, 0.01, and 0.007, respectively, with 42.7 mg Zn/kg representing the approximate breakpoint in the response of cardiac zinc concentration to changes in the dietary zinc concentration). There was no significant correlation evident in groups fed >42.7 mg Zn/kg (r = 20.44, 20.92, and 20.88 with P = 0.56, 0.08, and 0.12, respectively) or when estimated over all feeding groups (r = 0.06, 0.55, and 0.45 with P = 0.46, 0.16, and 0.27, respectively).
There were no significant associations between the expression of other cardiac genes (BAX, CASP3, CASP8, CASP9, GADD45A, GPX1, IGFBP3, PRDX1, PRDX3, PRDX4, SOD1, SOD2, CAT, GSR, MT1A, MT2B) or cardiac antioxidative capacity (GSH, GSSG, GSH:GSSG, HDA, a-tocopherol) (P > 0.8 in all cases; data not shown).
Discussion
We studied short-term differences in dietary zinc concentrations above and below the estimated gross zinc requirement for piglets (7, 13) . Because the cardiac GSSG concentrations did not substantially change during this study, the reduction in cardiac GSH may have resulted from reduced synthesis or increased degradation rather than increased oxidation. Furthermore, the breakpoint in the response of GSH to dietary zinc corresponds to the point of the satisfied gross zinc requirement (58.0 mg Zn/kg).
Therefore, we conclude that GSH was affected in a zinc-supply status-dependent manner. Considering the response patterns of cardiac HDA and a-tocopherol, our data suggests a decrease in the heart antioxidative capacity during short-term SZD.
However, decreasing tissue a-tocopherol concentrations may not necessarily reflect increased oxidation but also reduced vitamin E uptake, although the supplementation of RRRa-tocopherol equivalents occurred equally and in adequate amounts to each experimental and control ration. Furthermore, the homogeneity of diets was excellent, as has been shown earlier (7) . Indeed, we previously recognized a decrease in apparent lipid digestibility (13) , which affects fat-soluble vitamin absorption from the gastrointestinal tract. However, the significant breakpoint in the response of apparent lipid digestibility to the dietary zinc concentration was 47.0 mg Zn/kg (13) . Hence, if decreased vitamin E uptake was responsible for the cardiac a-tocopherol depletion, the breakpoint in the response of a-tocopherol should have been in the same range. Furthermore, the total differences in fat digestion were probably too low to promote substantial changes within the timeframe of this experiment. Therefore, we suggest that the reduction in cardiac a-tocopherol concentration was mainly caused by an increased a-tocopherol oxidation through lipid peroxides.
The changes in the redox metabolism parameters were associated with an increase in the expression of proapoptotic genes (BAX, CASP9). Oltvai et al. (18) identified an association between higher BAX expression and increased apoptosis that seemed to have been due to a modulation of the permeability of the outer mitochondrial membrane by BAX, which promotes the efflux of cytochrome c into the cytosol (19) . In response to this efflux, a signaling cascade during which the activator CASP9 initiates effector CASP3 facilitates apoptosis (20) . The upregulation of BAX and CASP9 in this study indicates increased intrinsic apoptotic signaling, which seems plausible considering a potential increase in a-tocopherol oxidation by membrane lipid peroxides.
GSR is an enzyme involved in converting GSSG back to GSH to restore its ability to detoxify ROS. Furthermore, catalase Cardiac response to subclinical zinc deficiency 525 activity detoxifies H 2 O 2 (21) . Previous studies have suggested that the expression of both genes (GSR and CAT) was upregulated during oxidative stress, which resulted in higher protein abundance and activity (22, 23) . This is consistent with our findings of increased GSR and CAT expression to the simultaneous decrease in GSH and HDA. Indeed, GSH and HDA were reduced over a broader range of dietary zinc intake than we recognized for the response of GSR and CAT. This indicates that piglets fed #40 mg Zn/kg experienced higher concentrations of ROS in the heart tissue than all other groups. The alterations in cardiac metabolism described previously raise the question about their functional relation to the dietary zinc supply. Our initial assumption was that a decrease in cardiac zinc status in response to declining dietary zinc intake promoted these adaptions. However, the curvilinear response of cardiac zinc does not support this hypothesis. Zinc is an important cofactor of gene expression mechanisms (24) . Therefore, the upregulation of cellular stress response may have fostered the increase in cardiac zinc concentration. This is supported by a positive correlation between the expression of FAS, EI24, and CDKN1A and cardiac zinc concentration in groups fed 28.1-42.7 mg Zn/kg. The TP53-regulated gene FAS codes for a so-called death receptor that induces an extrinsic proapoptotic pathway after binding the FAS ligand (25) . Increased expression of EI24 in response to TP53 has been linked to impaired cell growth and increased apoptosis (26, 27) . As a potential B-cell lymphoma 2-binding protein, it may be involved in intrinsic proapoptotic signaling (28) . The gene CDKN1A causes gap 1 cell-cycle arrest in response to TP53 (29) . Taken together, the increase in cardiac zinc concentration seemed to represent a compensatory response to facilitate stress-associated gene expression in response to increased oxidative stress.
The decline in the concentration of MT1A mRNA may support this hypothesis. MT1A expression is regulated by the amount of cytosolic free zinc ions, which activate metalregulatory transcription factor 1 (30) . The reduction of MT1A gene expression inversely to the increase in cardiac zinc concentration might indicate a lower necessity for capturing free zinc ions in the heart muscles of piglets fed #42.7 mg Zn/kg. This may have been caused by a direct transfer of zinc to other zinc-binding peptides, especially stress-associated transcription factors such as TP53. Interestingly, MT1A gene expression exhibited a strong and significant correlation to HDA (r = 0.91; P = 0.002; data not shown). It has been shown that a reduction of metallothioneins in the course of zinc deficiency can promote oxidative stress (31, 32) . Therefore, apart from other parameters such as GSH, a decrease in cardiac metallothioneins may have contributed to the observed reduction of HDA.
Although we recognized changes in the behavior of TP53 target genes, TP53 expression was not affected by changes in dietary or cardiac zinc concentration. Indeed, TP53 is also regulated by other factors, e.g., its phosphorylation pattern (33) . Table 3 for the statistical measures of the respective regression models). Values are arithmetic means 6 SDs, n = 6. Diet zinc, dietary zinc; DM, dry matter; Log 10 (2 2DDCt ), decadal logarithm of the relative gene expression value according to Livak and Schmittgen (17) ; MT1A, metallothionein 1a. Some studies have reported an upregulation of TP53 under certain treatment conditions [e.g., Ho et al. (34) ]. Therefore, our experimental design does not seem to have induced a stimulus that was strong enough to promote TP53 transcription.
In conclusion, short-term SZD in weaned piglets was associated with decreased heart antioxidative capacity and increased cardiac proapoptotic and antioxidative gene expression. Contrary to our initial hypothesis, however, the cardiac zinc concentration increased in piglets fed less than the estimated gross zinc requirement. This correlated positively to the relative expression of further stress-responsive genes in cardiac tissue. We conclude that this represented a compensatory response in times of increased cardiac ROS concentrations as an attempt to maintain tissue integrity. Remarkably, these adaptions were evident after just 8 d of insufficient dietary zinc supply. To our knowledge, this is the first study to report experimental data on the relation between SZD and redox metabolism.
